Why the long wait for gene-specific drugs? Personalised medicine has been a long time coming, and now researchers are wising up to the realities
New Scientist
Peter Aldhous
27 October 2007
LabCorp signs research agreement with drug company
McClatchy-Tribune Regional News
By Keren Rivas, Times-News, Burlington, N.C.
23 October 2007
New diagnostics: Advances in immunoassay technology, genomic testing are poised to change industry structure.(Report)
Biomedical Business & Technology
Simonsen, Michael
1 October 2007
THIRD WAVE HELPING DEVELOP TEST FOR HEART FAILURE DRUG
The Capital Times & Wisconsin State Journal
1 September 2007
Agreements
1 August 2007
Biomedical Business & Technology
Colo. companies raise $284.9 million in venture capital
Associated Press Newswires
24 July 2007
Businesses rely on phase value
Denver Post
By Kimberly S. Johnson and Zach Fox
23 June 2007
ARCA Discovery raises $18M for cardiovascular drug
VentureBeat
By David Hamilton
12 June 2007
ARCA Raises $18M For Genetic Heart-Failure Drug
DowJones Venture Capital
By Brian Gormley
8 June 2007
ARCA Discovery’s Drug, Dx NDA for Bucindolol Could Spawn PGx Future for Other Beta Blockers
Pharmagocenomics Reporter
July 26, 2006
Gene tests as potential guides for treatments
International Herald Tribune
July 12, 2006
Responsive Gene Is Key to Efficiency of Heart-Failure Drug
Washington Post
July 11, 2006
A Tale of Two Drugs Hints at Promise for Genetic Testing
NY Times
July 11, 2006
Heart drug riddle solved
Baltimore Sun
July 11, 2006
Genetic Variation Found that Predicts Response to Heart Failure Medication
University of Colorado
July 10, 2006
Gene Test May Improve Drug Treatment in Chronic Heart Failure
Bloomberg News
July 10, 2006
Failed heart drug could be a ‘genetically targeted’ success
USA Today
July 10, 2006
Trying to Unlock Heart’s Genetic Key
Venture Capital Analyst
April, 2006
Venture Wire Alert – venture market summary
Dow Jones Venture Wire
March 3, 2006
